Streetbeat News

Regulatory

VGK

European Central Bank's President, Christine Lagarde, has indicated that economic growth is expected to be subdued, with recent indicators suggesting a weak Q3. This could potentially impact the performance of the Vanguard FTSE Europe ETF (VGK), which tracks the performance of the European stock market.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:55 pm

CYTO

Altamira Therapeutics has reported additional efficacy outcomes from its Bentrio clinical trial in seasonal allergic rhinitis. The NASAR clinical trial demonstrated the efficacy and tolerability of Bentrio nasal spray in treating seasonal allergic rhinitis, meeting both primary and secondary efficacy endpoints. The treatment also showed a statistically significant improvement in health-related quality of life secondary efficacy endpoint. The efficacy was demonstrated from the first day of the 2-week treatment period and across allergy symptoms and functional problems. Bentrio treatment was associated with a reduced need for relief medication.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:49 pm

BNBUSD

COIN

ETHUSD

XRPUSD

Ethereum co-founder, Joseph Lubin, expressed confidence that disagreements between crypto companies and the SEC will be resolved favorably. He drew parallels with past technological advancements and emphasized that decentralized protocols, blockchain, and cryptocurrency align with U.S. philosophies. Major crypto entities, including Binance, Coinbase, and Ripple, are currently in legal battles with the SEC over alleged regulatory breaches.

Portfolio Pulse from Murtuza Merchant

September 14, 2023 | 12:47 pm

HEPA

Hepion Pharmaceuticals' drug, Rencofilstat, has shown positive outcomes in a translational study on Idiopathic Pulmonary Fibrosis (IPF). Proteomics analysis revealed that Rencofilstat improved aberrant protein profiles in IPF tissues. The drug showed superior effects alone and in combination with pirfenidone and nintedanib.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:47 pm

SPY

The USA Core Producer Price Index (PPI) for August was reported at 0.2%, in line with estimates but lower than the 0.4% reported in the previous month.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:42 pm

EVOK

Evoke Pharma has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application related to Gimoti, an FDA-approved nasal formulation of Metoclopramide. The patent will cover the intranasal pharmaceutical composition.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:40 pm

NBIX

The FDA has accepted to review Neurocrine Biosciences' New Drug Application for Ingrezza (Valbenazine) oral granules. The Prescription Drug User Fee Act target action date is April 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:36 pm

VGK

The Euro Zone Marginal Lending Facility Rate has increased to 4.75% from the previous rate of 4.50%.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:19 pm

VGK

The Eurozone has decided to increase its interest rate to 4.50% from the previous 4.25%, which is higher than the estimated 4.25%.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:19 pm

VGK

The European Central Bank (ECB) has increased its deposit rate from 3.75% to 4.00%.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:18 pm